Review Of The Drug Enforcement Administration's (DEA) Control Of The Diversion Of Controlled Pharmaceuticals
- NARA ID
- review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Source
- oig-doj
- Collection
- DOJ OIG — Other
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2002-09-01
- Slug
- doj-oig-review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Indexed
- 2026-04-27 05:13:58
More from DOJ OIG — Other
- Examination of the U.S. Department of Justice's Fiscal Year 2017 Compliance under the Improper Payments Elimination and Recovery Act of 2010
- Report to Congress on Implementation of Section 1001 of the USA PATRIOT Act
- The Department of Justice's Victim Notification System
- Grants to Encourage Arrest Policies Administered by the Osage Tribal Council
- The Federal Bureau of Prisons' Drug Interdiction Activities
- Boot Camp Construction Grant Administered by the Department of Corrections
About the DOJ OIG — Other collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning this DOJ component.